MedPath

重庆赛维药业有限公司

Ownership
-
Established
2003-06-05
Employees
-
Market Cap
-
Website
www.succeway.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Quetiapine Fumarate Sustained-release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20193232
Approval Date
Aug 6, 2024
NMPA

Quetiapine Furmarate Sustained-release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20193233
Approval Date
Aug 6, 2024
NMPA

Quetiapine Furmarate Sustained-release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20193234
Approval Date
Aug 6, 2024
NMPA

Quetiapine Furmarate Sustained-release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20193235
Approval Date
Aug 6, 2024
NMPA

Quetiapine Fumarate Sustained-release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20193231
Approval Date
Aug 6, 2024
NMPA

Benzidamine Hydrochloride

Product Name
盐酸苄达明
Approval Number
国药准字H20084629
Approval Date
Oct 24, 2023
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20130064
Approval Date
Jun 9, 2023
NMPA

Pregabalin

Product Name
普瑞巴林
Approval Number
国药准字H20130066
Approval Date
Jun 9, 2023
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20130065
Approval Date
Jun 9, 2023
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20130073
Approval Date
Jun 9, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy